Zhu, Qiyu
Liu, Dingbang
Liu, Haoyang
Pan, Xiaohui
Shi, Yifu
Guo, Jingjing
Tong, Nanwei
Chen, Junru
Zeng, Hao
Funding for this research was provided by:
National Natural Science Foundation of China (NSFC 82203110, 82172785, and 81974398)
1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYJC21020, ZYGD22004)
Science and Technology Support Program of Sichuan Province (2021YFS0119)
Clinical and Translational Medicine Research Project, Chinese Academy of Medical Sciences (2022-I2M-C&T-B-098)
Bethune Foundation, Oncology Basic Research Program (X-J-2020-016)
Bethune Foundation, Urological Oncology Special Research Fund (mnzl202002, mnzl202007)
Article History
Received: 18 November 2024
Accepted: 24 March 2025
First Online: 31 March 2025
Declarations
:
: The ethic approval was waived by West China Hospital ethics committee for studies involving humans as ethical approval was obtained from Ethical Committees in each original study. The written inform consent from each patients were also waived by ethics committee/institutional review board of West China Hospital because all participants gave inform consent to institution which conduct the original studies.
: Not applicable.
: The authors declare no competing interests.